The Pause: Honoring the Dead in COVID-19 to Advance Care
Healthcare professionals around the world are finding ways to honor the lives of patients who die and take part in some self-care, which is particularly important during this time of crisis.
Related Articles
Home
Friday, Jun 21, 2024 | 9:25 am – 10:25 am CT Supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. Join us for…
Stimulants for ADHD Not Linked to Prescription Drug Misuse
Concerns have been raised that teens who take stimulants for ADHD may have an increased risk for prescription drug misuse, but this study found no…
Wide Disparity in Mental Telehealth Services Among States
This study found wide state-to-state discrepancies in the availability of telehealth for mental healthcare.
ED Visits for Cannabis Use a Harbinger of Anxiety Disorder
Emergency department visits for cannabis use are associated with an increased risk for a subsequent healthcare visit for an anxiety disorder, data suggested.
Chasing the Blues…With Blueberries
Blueberries might hold an important key to staving off depression in early adults.
Parent-Led Digital CBT Effective for Childhood Anxiety
Parent-led digital cognitive behavioral therapy, with remote therapist support, worked as well as traditional CBT while saving therapist time and money, in a controlled trial.
Higher Risk for Death After Benzodiazepine Discontinuation
These medications must be tapered slowly to avoid causing severe withdrawal symptoms, said an addiction medicine specialist.
Will a Court Ruling Push the DEA to Reschedule Psilocybin?
A court victory on rescheduling psilocybin leads the plaintiffs to believe that a separate pending case could allow the drug’s use under right-to-try laws.
Telephone Intervention Reduces Depression, Loneliness
A brief, telephone-based psychological intervention delivered to seniors in the United Kingdom during COVID-19 pandemic mitigated symptoms of depression, new study results showed.
Study Suggests Mind-Body Benefits of GLP-1s
Med record data shows improvements in anxiety and depression in people taking the drugs for either diabetes or obesity.